Overall world revenue for the Biologics Market: In terms of value the market will surpass US$450.0 billion in 2025, the work calculates. The publisher predicts strong revenue growth through to 2035. The work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Recent advancements have broadened the therapeutic applications of biologics. For instance, an IL-31 inhibitor biologic developed by Galderma, for individuals aged 12 and older with moderate to severe atopic dermatitis. This approval introduces a new option for managing this chronic skin condition.
This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Escalating Demand for Biologics is Boosting the Market Growth
The escalating demand for biologics continues to be a significant driver of growth in the pharmaceutical market as of 2025. Biologics-therapies derived from living organisms-are renowned for their precision in targeting specific molecules or cells, leading to effective treatments with reduced side effects. This precision makes them particularly valuable in addressing complex medical conditions such as cancer, autoimmune disorders, and rare genetic diseases.Recent advancements have broadened the therapeutic applications of biologics. For instance, an IL-31 inhibitor biologic developed by Galderma, for individuals aged 12 and older with moderate to severe atopic dermatitis. This approval introduces a new option for managing this chronic skin condition.
Key Questions Answered
- How is the biologics market evolving?
- What is driving and restraining the biologics market?
- How will each biologics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
- How will the market shares for each biologics submarket develop from 2025 to 2035?
- What will be the main driver for the overall market from 2025 to 2035?
- Will leading biologics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
- Who are the leading players and what are their prospects over the forecast period?
- What are the biologics projects for these leading companies?
- How will the industry evolve during the period between 2025 and 2035? What are the implications of biologics projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the biologics market?
- Where is the biologics market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the biologics market today, and over the next 10 years:
- This 367-page report provides 136 tables and 228 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2035 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2035, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biologics prices and recent developments.
Segments Covered in the Report
Product
- Monoclonal Antibodies
- Human
- Humanized
- Chimeric
- Murine
- Vaccines
- Recombinant Proteins
- Regenerative Medicine
- Tissue Engineered Products
- Cell Therapy
- Gene Therapies
- Others
Application
- Oncology
- Infectious Diseases
- Autoimmune Disease
- Haematological Disorder
- Cardiovascular Disorders
- Others
Manufacturing Type
- Outsource
- In-house
Source
- Mammalian
- Microbial
- Others
End-users
- Hospitals
- Speciality Centres
- Others
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- South-East Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
Leading companies and the potential for market growth
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca plc
- Biogen Inc.
- Bristol-Myers Squibb Company
- Celltrion, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- Johnson & Johnson
- Merck & Co.
- Novo Nordisk A/S
- Pfizer Inc.
- Regeneron Pharmaceuticals, Inc.
- Sanofi
How will the Biologics Market report help you?
In summary, the 360+ page report provides you with the following knowledge:- Revenue forecasts to 2035 for Biologics Market, with forecasts for product, application, manufacturing type, source, and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2035 for five regional and 24 key national markets - See forecasts for the Biologics Market in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 16 of the major companies involved in the Biologics Market.
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Biologics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
1.2 Introduction to Biologics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Rising Demand for Biologics
3.3.1.2 Advancements in Biomedical Science
3.3.1.3 Rising Investments in Biopharmaceutical R&D
3.3.1.4 Rising Prevalence of Chronic Diseases
3.3.1.5 Increase in Number of Elderly Population will Drive the Market Growth
3.3.2 Market Restraining Factors
3.3.2.1 High Production Costs
3.3.2.2 Navigating Immunogenicity and Adverse Reactions in Biologics Development
3.3.2.3 High Stringency and Low Turnover for Clinical Trials
3.3.3 Market Opportunities
3.3.3.1 Mergers, Acquisitions, and Collaborations in Biologics
3.3.3.2 Surging Drug Approvals and Launches of Biologics
3.3.3.3 Increasing Outsourcing of Biopharmaceutical Activities to CROs
3.3.3.4 Emerging Economies Expansion and Prioritisation of R&D
3.4 Porter's Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.6 The Rise of Biologics in Modern Medicine
3.6.1 Navigating New Frontiers in GI Disease Treatment
3.6.2 Transforming Food Allergy Treatment
3.6.3 Challenges in Biologics: Production and Delivery
3.6.4 The Future Looks Bright
3.6.5 Precision Medicine: The Next Frontier
3.6.6 Advancing Drug Delivery Techniques
3.6.7 Navigating the Future of Biologics with Optimism and Awareness
3.7 Navigating the Biologics Manufacturing Lifecycle: From Preclinical to Clinical
3.7.1 The Journey from Preclinical Development to Clinical Manufacturing in Biologics
3.7.2 What Does the Biologics Journey from Preclinical Development to Clinical Manufacturing Look Like?
3.7.3 Key Challenges in the Transition from Preclinical Development to Clinical Manufacturing
3.7.4 Innovations and Emerging Trends Shaping Biologics Manufacturing
3.7.5 Advice for Teams Embarking on Biologics Development
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Rising Demand for Biologics
3.3.1.2 Advancements in Biomedical Science
3.3.1.3 Rising Investments in Biopharmaceutical R&D
3.3.1.4 Rising Prevalence of Chronic Diseases
3.3.1.5 Increase in Number of Elderly Population will Drive the Market Growth
3.3.2 Market Restraining Factors
3.3.2.1 High Production Costs
3.3.2.2 Navigating Immunogenicity and Adverse Reactions in Biologics Development
3.3.2.3 High Stringency and Low Turnover for Clinical Trials
3.3.3 Market Opportunities
3.3.3.1 Mergers, Acquisitions, and Collaborations in Biologics
3.3.3.2 Surging Drug Approvals and Launches of Biologics
3.3.3.3 Increasing Outsourcing of Biopharmaceutical Activities to CROs
3.3.3.4 Emerging Economies Expansion and Prioritisation of R&D
3.4 Porter's Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.6 The Rise of Biologics in Modern Medicine
3.6.1 Navigating New Frontiers in GI Disease Treatment
3.6.2 Transforming Food Allergy Treatment
3.6.3 Challenges in Biologics: Production and Delivery
3.6.4 The Future Looks Bright
3.6.5 Precision Medicine: The Next Frontier
3.6.6 Advancing Drug Delivery Techniques
3.6.7 Navigating the Future of Biologics with Optimism and Awareness
3.7 Navigating the Biologics Manufacturing Lifecycle: From Preclinical to Clinical
3.7.1 The Journey from Preclinical Development to Clinical Manufacturing in Biologics
3.7.2 What Does the Biologics Journey from Preclinical Development to Clinical Manufacturing Look Like?
3.7.3 Key Challenges in the Transition from Preclinical Development to Clinical Manufacturing
3.7.4 Innovations and Emerging Trends Shaping Biologics Manufacturing
3.7.5 Advice for Teams Embarking on Biologics Development
4 Biologics Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Biologics Market Size Estimation and Forecast by Product
4.4 Monoclonal Antibodies
4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.4.3 Human
4.4.3.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.3.2 Market Share by Region, 2024 & 2034 (%)
4.4.4 Humanized
4.4.4.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.4.2 Market Share by Region, 2024 & 2034 (%)
4.4.5 Chimeric
4.4.5.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.5.2 Market Share by Region, 2024 & 2034 (%)
4.4.6 Murine
4.4.6.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.6.2 Market Share by Region, 2024 & 2034 (%)
4.5 Vaccines
4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2025 & 2035 (%)
4.6 Recombinant Proteins
4.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2025 & 2035 (%)
4.7 Regenerative Medicine
4.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2025 & 2035 (%)
4.7.3 Tissue Engineered Products
4.7.3.1 Market Size by Region, 2025-2035 (US$ Billion)
4.7.3.2 Market Share by Region, 2024 & 2034 (%)
4.7.4 Cell Therapy
4.7.4.1 Market Size by Region, 2025-2035 (US$ Billion)
4.7.4.2 Market Share by Region, 2024 & 2034 (%)
4.7.5 Gene Therapies
4.7.5.1 Market Size by Region, 2025-2035 (US$ Billion)
4.7.5.2 Market Share by Region, 2024 & 2034 (%)
4.8 Others
4.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.8.2 Market Share by Region, 2025 & 2035 (%)
4.2 Product Segment: Market Attractiveness Index
4.3 Biologics Market Size Estimation and Forecast by Product
4.4 Monoclonal Antibodies
4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.4.3 Human
4.4.3.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.3.2 Market Share by Region, 2024 & 2034 (%)
4.4.4 Humanized
4.4.4.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.4.2 Market Share by Region, 2024 & 2034 (%)
4.4.5 Chimeric
4.4.5.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.5.2 Market Share by Region, 2024 & 2034 (%)
4.4.6 Murine
4.4.6.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.6.2 Market Share by Region, 2024 & 2034 (%)
4.5 Vaccines
4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2025 & 2035 (%)
4.6 Recombinant Proteins
4.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2025 & 2035 (%)
4.7 Regenerative Medicine
4.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2025 & 2035 (%)
4.7.3 Tissue Engineered Products
4.7.3.1 Market Size by Region, 2025-2035 (US$ Billion)
4.7.3.2 Market Share by Region, 2024 & 2034 (%)
4.7.4 Cell Therapy
4.7.4.1 Market Size by Region, 2025-2035 (US$ Billion)
4.7.4.2 Market Share by Region, 2024 & 2034 (%)
4.7.5 Gene Therapies
4.7.5.1 Market Size by Region, 2025-2035 (US$ Billion)
4.7.5.2 Market Share by Region, 2024 & 2034 (%)
4.8 Others
4.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.8.2 Market Share by Region, 2025 & 2035 (%)
5 Biologics Market Analysis by Source
5.1 Key Findings
5.2 Source Segment: Market Attractiveness Index
5.3 Biologics Market Size Estimation and Forecast by Source
5.4 Mammalian
5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Microbial
5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Others
5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2025 & 2035 (%)
5.2 Source Segment: Market Attractiveness Index
5.3 Biologics Market Size Estimation and Forecast by Source
5.4 Mammalian
5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Microbial
5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Others
5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2025 & 2035 (%)
6 Biologics Market Analysis by Application
6.1 Key Findings
6.2 Application Segment: Market Attractiveness Index
6.3 Biologics Market Size Estimation and Forecast by Application
6.4 Oncology
6.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.4.2 Market Share by Region, 2025 & 2035 (%)
6.5 Infectious Diseases
6.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.5.2 Market Share by Region, 2025 & 2035 (%)
6.6 Autoimmune Disease
6.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.6.2 Market Share by Region, 2025 & 2035 (%)
6.7 Haematological Disorder
6.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.7.2 Market Share by Region, 2025 & 2035 (%)
6.8 Cardiovascular Disorders
6.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.8.2 Market Share by Region, 2025 & 2035 (%)
6.9 Others
6.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.9.2 Market Share by Region, 2025 & 2035 (%)
6.2 Application Segment: Market Attractiveness Index
6.3 Biologics Market Size Estimation and Forecast by Application
6.4 Oncology
6.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.4.2 Market Share by Region, 2025 & 2035 (%)
6.5 Infectious Diseases
6.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.5.2 Market Share by Region, 2025 & 2035 (%)
6.6 Autoimmune Disease
6.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.6.2 Market Share by Region, 2025 & 2035 (%)
6.7 Haematological Disorder
6.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.7.2 Market Share by Region, 2025 & 2035 (%)
6.8 Cardiovascular Disorders
6.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.8.2 Market Share by Region, 2025 & 2035 (%)
6.9 Others
6.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.9.2 Market Share by Region, 2025 & 2035 (%)
7 Biologics Market Analysis by Manufacturing Type
7.1 Key Findings
7.2 Manufacturing Type Segment: Market Attractiveness Index
7.3 Biologics Market Size Estimation and Forecast by Manufacturing Type
7.4 Outsource
7.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.4.2 Market Share by Region, 2025 & 2035 (%)
7.5 In-house
7.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.5.2 Market Share by Region, 2025 & 2035 (%)
7.2 Manufacturing Type Segment: Market Attractiveness Index
7.3 Biologics Market Size Estimation and Forecast by Manufacturing Type
7.4 Outsource
7.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.4.2 Market Share by Region, 2025 & 2035 (%)
7.5 In-house
7.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.5.2 Market Share by Region, 2025 & 2035 (%)
8 Biologics Market Analysis by End-users
8.1 Key Findings
8.2 End-users Segment: Market Attractiveness Index
8.3 Biologics Market Size Estimation and Forecast by End-users
8.4 Hospitals
8.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
8.4.2 Market Share by Region, 2025 & 2035 (%)
8.5 Speciality Centres
8.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
8.5.2 Market Share by Region, 2025 & 2035 (%)
8.6 Others
8.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
8.6.2 Market Share by Region, 2025 & 2035 (%)
8.2 End-users Segment: Market Attractiveness Index
8.3 Biologics Market Size Estimation and Forecast by End-users
8.4 Hospitals
8.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
8.4.2 Market Share by Region, 2025 & 2035 (%)
8.5 Speciality Centres
8.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
8.5.2 Market Share by Region, 2025 & 2035 (%)
8.6 Others
8.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
8.6.2 Market Share by Region, 2025 & 2035 (%)
9 Biologics Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast
9.2 Regional Market Size Estimation and Forecast
10 North America Biologics Market Analysis
10.1 Key Findings
10.2 North America Biologics Market Attractiveness Index
10.3 North America Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
10.4 North America Biologics Market Size Estimation and Forecast by Country
10.5 North America Biologics Market Size Estimation and Forecast by Product
10.6 North America Biologics Market Size Estimation and Forecast by Source
10.7 North America Biologics Market Size Estimation and Forecast by Application
10.8 North America Biologics Market Size Estimation and Forecast by Manufacturing Type
10.9 North America Biologics Market Size Estimation and Forecast by End-users
10.10 U.S. Biologics Market Analysis
10.11 Canada Biologics Market Analysis
10.2 North America Biologics Market Attractiveness Index
10.3 North America Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
10.4 North America Biologics Market Size Estimation and Forecast by Country
10.5 North America Biologics Market Size Estimation and Forecast by Product
10.6 North America Biologics Market Size Estimation and Forecast by Source
10.7 North America Biologics Market Size Estimation and Forecast by Application
10.8 North America Biologics Market Size Estimation and Forecast by Manufacturing Type
10.9 North America Biologics Market Size Estimation and Forecast by End-users
10.10 U.S. Biologics Market Analysis
10.11 Canada Biologics Market Analysis
11 Europe Biologics Market Analysis
11.1 Key Findings
11.2 Europe Biologics Market Attractiveness Index
11.3 Europe Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
11.4 Europe Biologics Market Size Estimation and Forecast by Country
11.5 Europe Biologics Market Size Estimation and Forecast by Product
11.6 Europe Biologics Market Size Estimation and Forecast by Source
11.7 Europe Biologics Market Size Estimation and Forecast by Application
11.8 Europe Biologics Market Size Estimation and Forecast by Manufacturing Type
11.9 Europe Biologics Market Size Estimation and Forecast by End-users
11.10 Germany Biologics Market Analysis
11.11 UK Biologics Market Analysis
11.12 France Biologics Market Analysis
11.13 Italy Biologics Market Analysis
11.14 Spain Biologics Market Analysis
11.15 Russia Biologics Market Analysis
11.16 Rest of Europe Biologics Market Analysis
11.2 Europe Biologics Market Attractiveness Index
11.3 Europe Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
11.4 Europe Biologics Market Size Estimation and Forecast by Country
11.5 Europe Biologics Market Size Estimation and Forecast by Product
11.6 Europe Biologics Market Size Estimation and Forecast by Source
11.7 Europe Biologics Market Size Estimation and Forecast by Application
11.8 Europe Biologics Market Size Estimation and Forecast by Manufacturing Type
11.9 Europe Biologics Market Size Estimation and Forecast by End-users
11.10 Germany Biologics Market Analysis
11.11 UK Biologics Market Analysis
11.12 France Biologics Market Analysis
11.13 Italy Biologics Market Analysis
11.14 Spain Biologics Market Analysis
11.15 Russia Biologics Market Analysis
11.16 Rest of Europe Biologics Market Analysis
12 Asia Pacific Biologics Market Analysis
12.1 Key Findings
12.2 Asia Pacific Biologics Market Attractiveness Index
12.3 Asia Pacific Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
12.4 Asia Pacific Biologics Market Size Estimation and Forecast by Country
12.5 Asia Pacific Biologics Market Size Estimation and Forecast by Product
12.6 Asia Pacific Biologics Market Size Estimation and Forecast by Source
12.7 Asia Pacific Biologics Market Size Estimation and Forecast by Application
12.8 Asia Pacific Biologics Market Size Estimation and Forecast by Manufacturing Type
12.9 Asia Pacific Biologics Market Size Estimation and Forecast by End-users
12.10 Japan Biologics Market Analysis
12.11 China Biologics Market Analysis
12.12 India Biologics Market Analysis
12.13 Australia Biologics Market Analysis
12.14 South Korea Biologics Market Analysis
12.15 South-East Asia Biologics Market Analysis
12.16 Rest of Asia Pacific Biologics Market Analysis
12.2 Asia Pacific Biologics Market Attractiveness Index
12.3 Asia Pacific Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
12.4 Asia Pacific Biologics Market Size Estimation and Forecast by Country
12.5 Asia Pacific Biologics Market Size Estimation and Forecast by Product
12.6 Asia Pacific Biologics Market Size Estimation and Forecast by Source
12.7 Asia Pacific Biologics Market Size Estimation and Forecast by Application
12.8 Asia Pacific Biologics Market Size Estimation and Forecast by Manufacturing Type
12.9 Asia Pacific Biologics Market Size Estimation and Forecast by End-users
12.10 Japan Biologics Market Analysis
12.11 China Biologics Market Analysis
12.12 India Biologics Market Analysis
12.13 Australia Biologics Market Analysis
12.14 South Korea Biologics Market Analysis
12.15 South-East Asia Biologics Market Analysis
12.16 Rest of Asia Pacific Biologics Market Analysis
13 Latin America Biologics Market Analysis
13.1 Key Findings
13.2 Latin America Biologics Market Attractiveness Index
13.3 Latin America Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
13.4 Latin America Biologics Market Size Estimation and Forecast by Country
13.5 Latin America Biologics Market Size Estimation and Forecast by Product
13.6 Latin America Biologics Market Size Estimation and Forecast by Source
13.7 Latin America Biologics Market Size Estimation and Forecast by Application
13.8 Latin America Biologics Market Size Estimation and Forecast by Manufacturing Type
13.9 Latin America Biologics Market Size Estimation and Forecast by End-users
13.10 Brazil Biologics Market Analysis
13.11 Mexico Biologics Market Analysis
13.12 Argentina Biologics Market Analysis
13.13 Colombia Biologics Market Analysis
13.14 Rest of Latin America Biologics Market Analysis
13.2 Latin America Biologics Market Attractiveness Index
13.3 Latin America Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
13.4 Latin America Biologics Market Size Estimation and Forecast by Country
13.5 Latin America Biologics Market Size Estimation and Forecast by Product
13.6 Latin America Biologics Market Size Estimation and Forecast by Source
13.7 Latin America Biologics Market Size Estimation and Forecast by Application
13.8 Latin America Biologics Market Size Estimation and Forecast by Manufacturing Type
13.9 Latin America Biologics Market Size Estimation and Forecast by End-users
13.10 Brazil Biologics Market Analysis
13.11 Mexico Biologics Market Analysis
13.12 Argentina Biologics Market Analysis
13.13 Colombia Biologics Market Analysis
13.14 Rest of Latin America Biologics Market Analysis
14 MEA Biologics Market Analysis
14.1 Key Findings
14.2 MEA Biologics Market Attractiveness Index
14.3 MEA Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
14.4 MEA Biologics Market Size Estimation and Forecast by Country
14.5 MEA Biologics Market Size Estimation and Forecast by Product
14.6 MEA Biologics Market Size Estimation and Forecast by Source
14.7 MEA Biologics Market Size Estimation and Forecast by Application
14.8 MEA Biologics Market Size Estimation and Forecast by Manufacturing Type
14.9 MEA Biologics Market Size Estimation and Forecast by End-users
14.10 GCC Biologics Market Analysis
14.11 South Africa Biologics Market Analysis
14.12 Rest of MEA Biologics Market Analysis
14.2 MEA Biologics Market Attractiveness Index
14.3 MEA Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
14.4 MEA Biologics Market Size Estimation and Forecast by Country
14.5 MEA Biologics Market Size Estimation and Forecast by Product
14.6 MEA Biologics Market Size Estimation and Forecast by Source
14.7 MEA Biologics Market Size Estimation and Forecast by Application
14.8 MEA Biologics Market Size Estimation and Forecast by Manufacturing Type
14.9 MEA Biologics Market Size Estimation and Forecast by End-users
14.10 GCC Biologics Market Analysis
14.11 South Africa Biologics Market Analysis
14.12 Rest of MEA Biologics Market Analysis
15 Company Profiles
15.1 Competitive Landscape
15.2 Johnson & Johnson
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue,2019-2024
15.2.3.2 R&D,2019-2024
15.2.3.3 Regional Market Shares, 2024
15.2.3.4 Business Market Shares, 2024
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 F. Hoffmann-La Roche AG
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2019-2024
15.3.3.2 R&D, 2019-2024
15.3.3.3 Business Market Shares, 2024
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Amgen Inc.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2019-2024
15.4.3.2 R&D, 2019-2024
15.4.3.3 Regional Market Shares, 2024
15.4.3.4 Business Market Shares, 2024
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 AbbVie Inc.
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2019-2024
15.5.3.2 R&D, 2019-2024
15.5.3.3 Regional Market Shares, 2024
15.5.3.4 Business Market Shares, 2024
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Novo Nordisk A/S
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2019-2024
15.6.3.2 R&D, 2019-2024
15.6.3.3 Regional Market Shares, 2024
15.6.3.4 Business Market Shares, 2024
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Eli Lilly and Company
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2019-2024
15.7.3.2 R&D, 2019-2024
15.7.3.3 Regional Market Shares, 2024
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Bristol-Myers Squibb Company
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2019-2024
15.8.3.2 R&D, 2019-2024
15.8.3.3 Regional Market Shares, 2024
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Merck & Co.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2019-2024
15.9.3.2 R&D, 2019-2024
15.9.3.3 Regional Market Shares, 2024
15.9.3.4 Business Market Shares, 2024
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 AstraZeneca plc
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2019-2024
15.10.3.2 R&D, 2019-2024
15.10.3.3 Regional Market Shares, 2024
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Sanofi
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2019-2024
15.11.3.2 R&D, 2019-2024
15.11.3.3 Regional Market Shares, 2024
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 Pfizer Inc.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2019-2024
15.12.3.2 R&D, 2019-2024
15.12.3.3 Regional Market Shares, 2024
15.12.3.4 Business Market Shares, 2024
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 Regeneron Pharmaceuticals, Inc.
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue,2019-2024
15.13.3.2 R&D,2019-2024
15.13.4 Product Benchmarking
15.13.5 Strategic Outlook
15.14 Gilead Sciences, Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.3.1 Net Revenue,2019-2024
15.14.3.2 R&D,2019-2024
15.14.3.3 Regional Market Shares, 2024
15.14.3.4 Business Market Shares, 2024
15.14.4 Product Benchmarking
15.14.5 Strategic Outlook
15.15 Celltrion, Inc.
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Product Benchmarking
15.15.4 Strategic Outlook
15.16 Biogen Inc.
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Financial Analysis
15.16.3.1 Net Revenue, 2019-2024
15.16.3.2 R&D, 2019-2024
15.16.3.3 Regional Market Shares, 2024
15.16.4 Product Benchmarking
15.16.5 Strategic Outlook
15.17 GSK plc
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue,2019-2024
15.17.3.2 R&D,2019-2024
15.17.3.3 Regional Market Shares, 2024
15.17.3.4 Business Market Shares, 2024
15.17.4 Product Benchmarking
15.17.5 Strategic Outlook
15.2 Johnson & Johnson
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue,2019-2024
15.2.3.2 R&D,2019-2024
15.2.3.3 Regional Market Shares, 2024
15.2.3.4 Business Market Shares, 2024
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 F. Hoffmann-La Roche AG
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2019-2024
15.3.3.2 R&D, 2019-2024
15.3.3.3 Business Market Shares, 2024
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Amgen Inc.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2019-2024
15.4.3.2 R&D, 2019-2024
15.4.3.3 Regional Market Shares, 2024
15.4.3.4 Business Market Shares, 2024
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 AbbVie Inc.
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2019-2024
15.5.3.2 R&D, 2019-2024
15.5.3.3 Regional Market Shares, 2024
15.5.3.4 Business Market Shares, 2024
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Novo Nordisk A/S
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2019-2024
15.6.3.2 R&D, 2019-2024
15.6.3.3 Regional Market Shares, 2024
15.6.3.4 Business Market Shares, 2024
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Eli Lilly and Company
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2019-2024
15.7.3.2 R&D, 2019-2024
15.7.3.3 Regional Market Shares, 2024
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Bristol-Myers Squibb Company
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2019-2024
15.8.3.2 R&D, 2019-2024
15.8.3.3 Regional Market Shares, 2024
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Merck & Co.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2019-2024
15.9.3.2 R&D, 2019-2024
15.9.3.3 Regional Market Shares, 2024
15.9.3.4 Business Market Shares, 2024
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 AstraZeneca plc
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2019-2024
15.10.3.2 R&D, 2019-2024
15.10.3.3 Regional Market Shares, 2024
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Sanofi
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2019-2024
15.11.3.2 R&D, 2019-2024
15.11.3.3 Regional Market Shares, 2024
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 Pfizer Inc.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2019-2024
15.12.3.2 R&D, 2019-2024
15.12.3.3 Regional Market Shares, 2024
15.12.3.4 Business Market Shares, 2024
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 Regeneron Pharmaceuticals, Inc.
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue,2019-2024
15.13.3.2 R&D,2019-2024
15.13.4 Product Benchmarking
15.13.5 Strategic Outlook
15.14 Gilead Sciences, Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.3.1 Net Revenue,2019-2024
15.14.3.2 R&D,2019-2024
15.14.3.3 Regional Market Shares, 2024
15.14.3.4 Business Market Shares, 2024
15.14.4 Product Benchmarking
15.14.5 Strategic Outlook
15.15 Celltrion, Inc.
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Product Benchmarking
15.15.4 Strategic Outlook
15.16 Biogen Inc.
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Financial Analysis
15.16.3.1 Net Revenue, 2019-2024
15.16.3.2 R&D, 2019-2024
15.16.3.3 Regional Market Shares, 2024
15.16.4 Product Benchmarking
15.16.5 Strategic Outlook
15.17 GSK plc
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue,2019-2024
15.17.3.2 R&D,2019-2024
15.17.3.3 Regional Market Shares, 2024
15.17.3.4 Business Market Shares, 2024
15.17.4 Product Benchmarking
15.17.5 Strategic Outlook
16 Conclusion and Recommendations
16.1 Concluding Remarks
16.2 Recommendations for Market Players
16.2 Recommendations for Market Players
List of Tables
Table 1 FDA Approved Cellular & Gene Therapies in 2024
Table 2 Biologics Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 3 Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 4 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 5 Human Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 6 Humanized Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 7 Chimeric Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 8 Murine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 10 Recombinant Proteins Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 11 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Tissue Engineered Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Cell Therapy Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 14 Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 17 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 18 Microbial Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 21 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 22 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 23 Autoimmune Disease Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 24 Haematological Disorder Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 25 Cardiovascular Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 26 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 27 Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 28 Outsource Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 29 In-house Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 30 Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 31 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 32 Speciality Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 33 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 34 Biologics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 35 North America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 36 North America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 37 North America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 38 North America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 39 North America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 40 North America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 41 U.S. Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 42 Canada Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 43 Europe Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 44 Europe Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 45 Europe Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 46 Europe Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 47 Europe Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 48 Europe Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 49 Germany Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 50 UK Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 51 France Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 52 Italy Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 53 Italy Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 54 Russia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 55 Rest of Europe Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 Asia Pacific Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 57 Asia Pacific Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 58 Asia Pacific Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 59 Asia Pacific Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 60 Asia Pacific Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 61 Asia Pacific Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 62 Japan Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 63 China Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 64 India Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 65 Australia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 66 South Korea Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 67 South-East Asia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 68 Rest of Asia Pacific Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 69 Latin America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 70 Latin America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 71 Latin America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 72 Latin America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 73 Latin America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 74 Latin America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 75 Brazil Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 76 Mexico Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 77 Argentina Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 78 Colombia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 79 Rest of Latin America Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 80 MEA Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 81 MEA Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 82 MEA Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 83 MEA Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 84 MEA Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 85 MEA Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 86 GCC Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 87 South Africa Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 88 Rest of MEA Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 89 Johnson & Johnson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Johnson & Johnson: Product Benchmarking
Table 91 Johnson & Johnson: Strategic Outlook
Table 92 F. Hoffmann-La Roche AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 F. Hoffmann-La Roche AG: Product Benchmarking
Table 94 F. Hoffmann-La Roche AG: Strategic Outlook
Table 95 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Amgen Inc.: Product Benchmarking
Table 97 Amgen Inc. Strategic Outlook
Table 98 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 AbbVie Inc.: Product Benchmarking
Table 100 AbbVie Inc.: Strategic Outlook
Table 101 Novo Nordisk A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Novo Nordisk A/S: Product Benchmarking
Table 103 Novo Nordisk A/S Strategic Outlook
Table 104 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Eli Lilly and Company: Product Benchmarking
Table 106 Eli Lilly and Company Strategic Outlook
Table 107 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Bristol-Myers Squibb Company: Product Benchmarking
Table 109 Bristol-Myers Squibb Company Strategic Outlook
Table 110 Merck & Co.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Merck & Co.: Product Benchmarking
Table 112 Merck & Co.: Strategic Outlook
Table 113 AstraZeneca plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 AstraZeneca plc: Product Benchmarking
Table 115 AstraZeneca plc Strategic Outlook
Table 116 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Sanofi: Product Benchmarking
Table 118 Sanofi Strategic Outlook
Table 119 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Pfizer Inc.: Product Benchmarking
Table 121 Pfizer Inc.: Strategic Outlook
Table 122 Regeneron Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 Regeneron Pharmaceuticals, Inc.: Product Benchmarking
Table 124 Regeneron Pharmaceuticals, Inc.: Strategic Outlook
Table 125 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Gilead Sciences, Inc.: Product Benchmarking
Table 127 Gilead Sciences, Inc.: Strategic Outlook
Table 128 Celltrion, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Celltrion, Inc.: Product Benchmarking
Table 130 Celltrion, Inc. Strategic Outlook
Table 131 Biogen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Biogen Inc.: Product Benchmarking
Table 133 Biogen Inc. Strategic Outlook
Table 134 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 GSK plc: Product Benchmarking
Table 136 GSK plc: Strategic Outlook
Table 2 Biologics Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 3 Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 4 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 5 Human Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 6 Humanized Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 7 Chimeric Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 8 Murine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 10 Recombinant Proteins Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 11 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Tissue Engineered Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Cell Therapy Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 14 Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 17 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 18 Microbial Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 21 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 22 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 23 Autoimmune Disease Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 24 Haematological Disorder Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 25 Cardiovascular Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 26 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 27 Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 28 Outsource Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 29 In-house Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 30 Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 31 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 32 Speciality Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 33 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 34 Biologics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 35 North America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 36 North America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 37 North America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 38 North America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 39 North America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 40 North America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 41 U.S. Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 42 Canada Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 43 Europe Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 44 Europe Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 45 Europe Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 46 Europe Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 47 Europe Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 48 Europe Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 49 Germany Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 50 UK Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 51 France Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 52 Italy Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 53 Italy Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 54 Russia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 55 Rest of Europe Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 Asia Pacific Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 57 Asia Pacific Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 58 Asia Pacific Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 59 Asia Pacific Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 60 Asia Pacific Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 61 Asia Pacific Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 62 Japan Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 63 China Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 64 India Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 65 Australia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 66 South Korea Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 67 South-East Asia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 68 Rest of Asia Pacific Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 69 Latin America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 70 Latin America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 71 Latin America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 72 Latin America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 73 Latin America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 74 Latin America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 75 Brazil Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 76 Mexico Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 77 Argentina Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 78 Colombia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 79 Rest of Latin America Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 80 MEA Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 81 MEA Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 82 MEA Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 83 MEA Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 84 MEA Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 85 MEA Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 86 GCC Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 87 South Africa Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 88 Rest of MEA Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 89 Johnson & Johnson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Johnson & Johnson: Product Benchmarking
Table 91 Johnson & Johnson: Strategic Outlook
Table 92 F. Hoffmann-La Roche AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 F. Hoffmann-La Roche AG: Product Benchmarking
Table 94 F. Hoffmann-La Roche AG: Strategic Outlook
Table 95 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Amgen Inc.: Product Benchmarking
Table 97 Amgen Inc. Strategic Outlook
Table 98 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 AbbVie Inc.: Product Benchmarking
Table 100 AbbVie Inc.: Strategic Outlook
Table 101 Novo Nordisk A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Novo Nordisk A/S: Product Benchmarking
Table 103 Novo Nordisk A/S Strategic Outlook
Table 104 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Eli Lilly and Company: Product Benchmarking
Table 106 Eli Lilly and Company Strategic Outlook
Table 107 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Bristol-Myers Squibb Company: Product Benchmarking
Table 109 Bristol-Myers Squibb Company Strategic Outlook
Table 110 Merck & Co.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Merck & Co.: Product Benchmarking
Table 112 Merck & Co.: Strategic Outlook
Table 113 AstraZeneca plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 AstraZeneca plc: Product Benchmarking
Table 115 AstraZeneca plc Strategic Outlook
Table 116 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Sanofi: Product Benchmarking
Table 118 Sanofi Strategic Outlook
Table 119 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Pfizer Inc.: Product Benchmarking
Table 121 Pfizer Inc.: Strategic Outlook
Table 122 Regeneron Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 Regeneron Pharmaceuticals, Inc.: Product Benchmarking
Table 124 Regeneron Pharmaceuticals, Inc.: Strategic Outlook
Table 125 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Gilead Sciences, Inc.: Product Benchmarking
Table 127 Gilead Sciences, Inc.: Strategic Outlook
Table 128 Celltrion, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Celltrion, Inc.: Product Benchmarking
Table 130 Celltrion, Inc. Strategic Outlook
Table 131 Biogen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Biogen Inc.: Product Benchmarking
Table 133 Biogen Inc. Strategic Outlook
Table 134 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 GSK plc: Product Benchmarking
Table 136 GSK plc: Strategic Outlook
List of Figures
Figure 1 Biologics Market Segmentation
Figure 2 Biologics Market by Product: Market Attractiveness Index
Figure 3 Biologics Market by Source: Market Attractiveness Index
Figure 4 Biologics Market by Application: Market Attractiveness Index
Figure 5 Biologics Market by Manufacturing Type: Market Attractiveness Index
Figure 6 Biologics Market by End-users: Market Attractiveness Index
Figure 7 Biologics Market Attractiveness Index by Region
Figure 8 Biologics Market: Market Dynamics
Figure 9 Biologics Market: Impact Analysis
Figure 10 Projected Number of People Aged 65 Years and Older
Figure 11 Biologics Market: Porter's Five Forces Analysis
Figure 12 Biologics Market: PEST Analysis
Figure 13 Biologics Market Attractiveness Index by Product
Figure 14 Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 15 Biologics Market Share Forecast by Product, 2025, 2030, 2035 (%)
Figure 16 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 17 Monoclonal Antibodies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 18 Human Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 19 Human Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 20 Humanized Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 21 Humanized Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Chimeric Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 23 Chimeric Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Murine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 25 Murine Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 27 Vaccines Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 28 Recombinant Proteins Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 29 Recombinant Proteins Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 30 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 31 Regenerative Medicine Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 32 Tissue Engineered Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 33 Tissue Engineered Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 34 Cell Therapy Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 35 Cell Therapy Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 37 Gene Therapies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 39 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 40 Biologics Market Attractiveness Index by Product
Figure 41 Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 42 Biologics Market Share Forecast by Source, 2025, 2030, 2035 (%)
Figure 43 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 44 Mammalian Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 45 Microbial Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 46 Microbial Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 47 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 48 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 49 Biologics Market Attractiveness Index by Application
Figure 50 Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 51 Biologics Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 52 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 53 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 54 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 55 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 56 Autoimmune Disease Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 57 Autoimmune Disease Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 58 Haematological Disorder Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 59 Haematological Disorder Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 60 Cardiovascular Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 61 Cardiovascular Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 62 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 63 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 64 Biologics Market Attractiveness Index by Manufacturing Type
Figure 65 Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 66 Biologics Market Share Forecast by Manufacturing Type, 2025, 2030, 2035 (%)
Figure 67 Outsource Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 68 Outsource Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 69 In-house Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 70 In-house Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 71 Biologics Market Attractiveness Index by End-users
Figure 72 Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 73 Biologics Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 74 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 75 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 76 Speciality Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 77 Speciality Centres Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 78 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 79 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 80 Biologics Market Forecast by Region 2025 & 2035 (Revenue, CAGR%)
Figure 81 Biologics Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 82 Biologics Market by Region, 2025-2035 (US$ Mn)
Figure 83 North America Biologics Market Attractiveness Index
Figure 84 North America Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 85 North America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 86 North America Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 87 North America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 88 North America Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 89 North America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 90 North America Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 91 North America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 92 North America Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 93 North America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 94 North America Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 95 North America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 96 North America Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 97 U.S. Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 98 Canada Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 99 Europe Biologics Market Attractiveness Index
Figure 100 Europe Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 101 Europe Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 102 Europe Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 103 Europe Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 104 Europe Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 105 Europe Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 106 Europe Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 107 Europe Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 108 Europe Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 109 Europe Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 110 Europe Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 111 Europe Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 112 Europe Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 113 Germany Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 114 UK Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 115 France Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 116 Italy Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 117 Spain Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 118 Russia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 119 Rest of Europe Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 120 Asia Pacific Biologics Market Attractiveness Index
Figure 121 Asia Pacific Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 122 Asia Pacific Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 123 Asia Pacific Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 124 Asia Pacific Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 125 Asia Pacific Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 126 Asia Pacific Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 127 Asia Pacific Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 128 Asia Pacific Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 129 Asia Pacific Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 130 Asia Pacific Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 131 Asia Pacific Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 132 Asia Pacific Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 133 Asia Pacific Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 134 Japan Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 135 China Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 136 India Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 137 Australia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 138 South Korea Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 139 South-East Asia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 140 Rest of Asia Pacific Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 141 Latin America Biologics Market Attractiveness Index
Figure 142 Latin America Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 143 Latin America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 144 Latin America Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 145 Latin America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 146 Latin America Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 147 Latin America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 148 Latin America Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 149 Latin America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 150 Latin America Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 151 Latin America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 152 Latin America Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 153 Latin America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 154 Latin America Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 155 Brazil Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 156 Mexico Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 157 Argentina Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 158 Colombia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 159 Rest of Latin America Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 160 MEA Biologics Market Attractiveness Index
Figure 161 MEA Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 162 MEA Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 163 MEA Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 164 MEA Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 165 MEA Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 166 MEA Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 167 MEA Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 168 MEA Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 169 MEA Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 170 MEA Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 171 MEA Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 172 MEA Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 173 MEA Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 174 GCC Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 175 South Africa Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 176 Rest of MEA Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 177 Johnson & Johnson: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 178 Johnson & Johnson: R&D, 2019-2024 (US$ Million, AGR%)
Figure 179 Johnson & Johnson: Regional Market Shares, 2024
Figure 180 Johnson & Johnson: Business Market Shares, 2024
Figure 181 F. Hoffmann-La Roche AG: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 182 F. Hoffmann-La Roche AG: R&D, 2019-2024 (US$ Million, AGR%)
Figure 183 F. Hoffmann-La Roche AG: Business Market Shares, 2024
Figure 184 Amgen Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 185 Amgen Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 186 Amgen Inc.: Regional Market Shares, 2024
Figure 187 Amgen Inc.: Business Market Shares, 2024
Figure 188 AbbVie Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 189 AbbVie Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 190 AbbVie Inc.: Regional Market Shares, 2024
Figure 191 AbbVie Inc.: Business Market Shares, 2024
Figure 192 Novo Nordisk A/S: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 193 Novo Nordisk A/S: R&D, 2019-2024 (US$ Million, AGR%)
Figure 194 Novo Nordisk A/S: Regional Market Shares, 2024
Figure 195 Novo Nordisk A/S: Business Market Shares, 2024
Figure 196 Eli Lilly and Company: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 197 Eli Lilly and Company: R&D, 2019-2024 (US$ Million, AGR%)
Figure 198 Eli Lilly and Company: Regional Market Shares, 2024
Figure 199 Bristol-Myers Squibb Company: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 200 Bristol-Myers Squibb Company: R&D, 2019-2024 (US$ Million, AGR%)
Figure 201 Bristol-Myers Squibb Company: Regional Market Shares, 2024
Figure 202 Merck & Co.: Net Revenue, 2019-2024(US$ Million, AGR%)
Figure 203 Merck & Co.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 204 Merck & Co.: Regional Market Shares, 2024
Figure 205 Merck & Co.: Business Market Shares, 2024
Figure 206 AstraZeneca plc: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 207 AstraZeneca plc: R&D, 2019-2024 (US$ Million, AGR%)
Figure 208 AstraZeneca plc: Regional Market Shares, 2024
Figure 209 Sanofi: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 210 Sanofi: R&D, 2019-2024 (US$ Million, AGR%)
Figure 211 Sanofi: Regional Market Shares, 2024
Figure 212 Pfizer Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 213 Pfizer Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 214 Pfizer Inc.: Regional Market Shares, 2024
Figure 215 Pfizer Inc.: Business Market Shares, 2024
Figure 216 Regeneron Pharmaceuticals, Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 217 Regeneron Pharmaceuticals, Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 218 Gilead Sciences, Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 219 Gilead Sciences, Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 220 Gilead Sciences, Inc.: Regional Market Shares, 2024
Figure 221 Gilead Sciences, Inc: Business Market Shares, 2024
Figure 222 Biogen Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 223 Biogen Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 224 Biogen Inc.: Regional Market Shares, 2024
Figure 225 GSK plc: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 226 GSK plc: R&D, 2019-2024 (US$ Million, AGR%)
Figure 227 GSK plc: Regional Market Shares, 2024
Figure 228 GSK plc: Business Market Shares, 2024
Figure 2 Biologics Market by Product: Market Attractiveness Index
Figure 3 Biologics Market by Source: Market Attractiveness Index
Figure 4 Biologics Market by Application: Market Attractiveness Index
Figure 5 Biologics Market by Manufacturing Type: Market Attractiveness Index
Figure 6 Biologics Market by End-users: Market Attractiveness Index
Figure 7 Biologics Market Attractiveness Index by Region
Figure 8 Biologics Market: Market Dynamics
Figure 9 Biologics Market: Impact Analysis
Figure 10 Projected Number of People Aged 65 Years and Older
Figure 11 Biologics Market: Porter's Five Forces Analysis
Figure 12 Biologics Market: PEST Analysis
Figure 13 Biologics Market Attractiveness Index by Product
Figure 14 Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 15 Biologics Market Share Forecast by Product, 2025, 2030, 2035 (%)
Figure 16 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 17 Monoclonal Antibodies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 18 Human Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 19 Human Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 20 Humanized Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 21 Humanized Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Chimeric Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 23 Chimeric Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Murine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 25 Murine Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 27 Vaccines Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 28 Recombinant Proteins Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 29 Recombinant Proteins Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 30 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 31 Regenerative Medicine Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 32 Tissue Engineered Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 33 Tissue Engineered Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 34 Cell Therapy Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 35 Cell Therapy Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 37 Gene Therapies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 39 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 40 Biologics Market Attractiveness Index by Product
Figure 41 Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 42 Biologics Market Share Forecast by Source, 2025, 2030, 2035 (%)
Figure 43 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 44 Mammalian Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 45 Microbial Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 46 Microbial Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 47 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 48 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 49 Biologics Market Attractiveness Index by Application
Figure 50 Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 51 Biologics Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 52 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 53 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 54 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 55 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 56 Autoimmune Disease Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 57 Autoimmune Disease Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 58 Haematological Disorder Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 59 Haematological Disorder Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 60 Cardiovascular Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 61 Cardiovascular Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 62 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 63 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 64 Biologics Market Attractiveness Index by Manufacturing Type
Figure 65 Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 66 Biologics Market Share Forecast by Manufacturing Type, 2025, 2030, 2035 (%)
Figure 67 Outsource Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 68 Outsource Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 69 In-house Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 70 In-house Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 71 Biologics Market Attractiveness Index by End-users
Figure 72 Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 73 Biologics Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 74 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 75 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 76 Speciality Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 77 Speciality Centres Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 78 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 79 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 80 Biologics Market Forecast by Region 2025 & 2035 (Revenue, CAGR%)
Figure 81 Biologics Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 82 Biologics Market by Region, 2025-2035 (US$ Mn)
Figure 83 North America Biologics Market Attractiveness Index
Figure 84 North America Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 85 North America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 86 North America Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 87 North America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 88 North America Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 89 North America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 90 North America Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 91 North America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 92 North America Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 93 North America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 94 North America Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 95 North America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 96 North America Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 97 U.S. Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 98 Canada Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 99 Europe Biologics Market Attractiveness Index
Figure 100 Europe Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 101 Europe Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 102 Europe Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 103 Europe Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 104 Europe Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 105 Europe Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 106 Europe Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 107 Europe Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 108 Europe Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 109 Europe Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 110 Europe Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 111 Europe Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 112 Europe Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 113 Germany Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 114 UK Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 115 France Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 116 Italy Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 117 Spain Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 118 Russia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 119 Rest of Europe Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 120 Asia Pacific Biologics Market Attractiveness Index
Figure 121 Asia Pacific Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 122 Asia Pacific Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 123 Asia Pacific Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 124 Asia Pacific Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 125 Asia Pacific Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 126 Asia Pacific Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 127 Asia Pacific Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 128 Asia Pacific Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 129 Asia Pacific Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 130 Asia Pacific Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 131 Asia Pacific Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 132 Asia Pacific Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 133 Asia Pacific Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 134 Japan Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 135 China Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 136 India Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 137 Australia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 138 South Korea Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 139 South-East Asia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 140 Rest of Asia Pacific Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 141 Latin America Biologics Market Attractiveness Index
Figure 142 Latin America Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 143 Latin America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 144 Latin America Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 145 Latin America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 146 Latin America Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 147 Latin America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 148 Latin America Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 149 Latin America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 150 Latin America Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 151 Latin America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 152 Latin America Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 153 Latin America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 154 Latin America Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 155 Brazil Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 156 Mexico Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 157 Argentina Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 158 Colombia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 159 Rest of Latin America Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 160 MEA Biologics Market Attractiveness Index
Figure 161 MEA Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 162 MEA Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 163 MEA Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 164 MEA Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 165 MEA Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 166 MEA Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 167 MEA Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 168 MEA Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 169 MEA Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 170 MEA Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 171 MEA Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 172 MEA Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 173 MEA Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 174 GCC Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 175 South Africa Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 176 Rest of MEA Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 177 Johnson & Johnson: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 178 Johnson & Johnson: R&D, 2019-2024 (US$ Million, AGR%)
Figure 179 Johnson & Johnson: Regional Market Shares, 2024
Figure 180 Johnson & Johnson: Business Market Shares, 2024
Figure 181 F. Hoffmann-La Roche AG: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 182 F. Hoffmann-La Roche AG: R&D, 2019-2024 (US$ Million, AGR%)
Figure 183 F. Hoffmann-La Roche AG: Business Market Shares, 2024
Figure 184 Amgen Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 185 Amgen Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 186 Amgen Inc.: Regional Market Shares, 2024
Figure 187 Amgen Inc.: Business Market Shares, 2024
Figure 188 AbbVie Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 189 AbbVie Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 190 AbbVie Inc.: Regional Market Shares, 2024
Figure 191 AbbVie Inc.: Business Market Shares, 2024
Figure 192 Novo Nordisk A/S: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 193 Novo Nordisk A/S: R&D, 2019-2024 (US$ Million, AGR%)
Figure 194 Novo Nordisk A/S: Regional Market Shares, 2024
Figure 195 Novo Nordisk A/S: Business Market Shares, 2024
Figure 196 Eli Lilly and Company: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 197 Eli Lilly and Company: R&D, 2019-2024 (US$ Million, AGR%)
Figure 198 Eli Lilly and Company: Regional Market Shares, 2024
Figure 199 Bristol-Myers Squibb Company: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 200 Bristol-Myers Squibb Company: R&D, 2019-2024 (US$ Million, AGR%)
Figure 201 Bristol-Myers Squibb Company: Regional Market Shares, 2024
Figure 202 Merck & Co.: Net Revenue, 2019-2024(US$ Million, AGR%)
Figure 203 Merck & Co.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 204 Merck & Co.: Regional Market Shares, 2024
Figure 205 Merck & Co.: Business Market Shares, 2024
Figure 206 AstraZeneca plc: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 207 AstraZeneca plc: R&D, 2019-2024 (US$ Million, AGR%)
Figure 208 AstraZeneca plc: Regional Market Shares, 2024
Figure 209 Sanofi: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 210 Sanofi: R&D, 2019-2024 (US$ Million, AGR%)
Figure 211 Sanofi: Regional Market Shares, 2024
Figure 212 Pfizer Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 213 Pfizer Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 214 Pfizer Inc.: Regional Market Shares, 2024
Figure 215 Pfizer Inc.: Business Market Shares, 2024
Figure 216 Regeneron Pharmaceuticals, Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 217 Regeneron Pharmaceuticals, Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 218 Gilead Sciences, Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 219 Gilead Sciences, Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 220 Gilead Sciences, Inc.: Regional Market Shares, 2024
Figure 221 Gilead Sciences, Inc: Business Market Shares, 2024
Figure 222 Biogen Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 223 Biogen Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 224 Biogen Inc.: Regional Market Shares, 2024
Figure 225 GSK plc: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 226 GSK plc: R&D, 2019-2024 (US$ Million, AGR%)
Figure 227 GSK plc: Regional Market Shares, 2024
Figure 228 GSK plc: Business Market Shares, 2024
Companies Mentioned
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca plc
- Biogen Inc.
- Bristol-Myers Squibb Company
- Celltrion, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- Johnson & Johnson
- Merck & Co.
- Novo Nordisk A/S
- Pfizer Inc.
- Regeneron Pharmaceuticals, Inc.
- Sanofi
